Article
A Precision Therapy Approach for Retinitis Pigmentosa 11 Using Splice-Switching Antisense Oligonucleotides to Restore the Open Reading Frame of PRPF31.
International journal of molecular sciences - 16 Mar 2024
Grainok Janya, Pitout Ianthe L, Chen Fred K, McLenachan Samuel, Heath Jeffery Rachael C, Mitrpant Chalermchai, Fletcher Sue
Abstract excerpt
Retinitis pigmentosa 11 is an untreatable, dominantly inherited retinal disease caused by heterozygous mutations in pre-mRNA processing factor 31 PRPF31. The expression level of PRPF31 is linked to incomplete penetrance in affected families; mutation carriers with higher PRPF31 expression can remain asymptomatic. The current study explores an antisense oligonucleotide exon skipping strategy to treat RP11 caused...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
